José Antonio Queizán

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

Carlos Santamaría, Ramón García‐Sánz, Cristina Pérez et al. · Blood · 2009 · 89 citations

Medicine, Hematology, Oncology +14

Validation of the <scp>NCCN</scp>‐<scp>IPI</scp> for diffuse large B‐cell lymphoma (<scp>DLBCL</scp>): the addition of β₂‐microglobulin yields a more accurate <scp>GELTAMO</scp>‐<scp>IPI</scp>

Carlos Montalbán, Antonio Díaz‐López, Iván Dlouhy et al. · British Journal of Haematology · 2017 · 82 citations · Full text

Medicine, Oncology, Cancer Immunology +13

Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma

Borja Puertas, Verónica González‐Calle, Eduardo Sobejano-Fuertes et al. · Cancers · 2023 · 73 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics

Carlos Santamaría, Ramón García‐Sánz, Cristina Pérez et al. · Leukemia Research · 2009 · 57 citations

Life Sciences, Molecular Biology, Oncology +10

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia

Miguel Quijada‐Álamo, María Hernández‐Sánchez, Cristina Robledo et al. · Journal of Hematology & Oncology · 2017 · 49 citations · Full text

Life Sciences, Genetics, Hematology +17